In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more




Additional contents from webparts:

Main Sponsor of EuroCMR 2012

SIEMENS

Gold Sponsor of EuroCMR 2012

GE

 



Overview and role of biopsy in myocarditis

Cristina BASSO | Padua, Italy

 

CMR to guide management of myocarditis

Matthias FRIEDRICH | Montreal, Canada

 

Quantification of fibrosis: tool or toy?

Andrew FLETT | London, UK

 

Outcome after myocarditis: emerging evidence of CMR

Oliver BRUDER | Essen, Germany




CMR methods for measuring the extracelluar volume in the heart

Peter KELLMAN | Bethesda, USA

 

Pre-clinical insights and validation of T1 and extracelluar volume mapping

Martin UGANDER | Stockholm, Sweden

 

Clinical application of T1 and extracelluar volume mapping

Andrew ARAI | Bethesda, USA



The emerging role of mapping relaxation times

Matthias FRIEDRICH | Montreal, Canada



Where CMR has changed clinical practice

Frank RADEMAKERS | Leuven, Belgium

 

Late-breaking data from the EuroCMR registry

Oliver BRUDER | Essen, Germany

 

Recent and ongoing imaging trials that can change clinical practice

John GREENWOOD | Leeds, UK

 

New CMR methods that will impact clinical practice within 5 years

Jürg SCHWITTER | Lausanne, Switzerland



Welcome Address

Herbert FRANK | Tulln, Austria